Skip to content
OpenCapital
Get started

Fortress Biotech FBIO Q4 2024 Annual earnings

Reported March 27, 2025 · Before market open

Revenue$15.1MMiss by $1.2MDiluted EPS-$0.53Beat by $0.26
Revenue estimate$16.3M
EPS estimate-$0.79

Next report

Aug 13, 2026 (in a month)
Revenue estimate$18.3M
EPS estimate-$0.20

Versus estimates

Revenue

Q1 2026$16.0MMiss by $300.0KQ4 2025$16.1MMiss by $10.1MQ3 2025$17.6MMiss by $3.4MQ2 2025$16.4MMiss by $4.6MQ1 2025$13.1MBeat by $1.5M
Q4 2024$15.1MMiss by $1.2M

Diluted EPS

Q1 2026$2.82Beat by $3.04Q4 2025-$0.21Miss by $0.63Q3 2025$0.11Beat by $0.54Q2 2025-$0.46Miss by $0.15Q1 2025-$1.03Miss by $0.59
Q4 2024-$0.53Beat by $0.26

Ask the moment Fortress Biotech reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Fortress Biotech report Q4 2024 earnings?
Fortress Biotech (FBIO) reported Q4 2024 earnings on March 27, 2025 before market open.
What were Fortress Biotech's Q4 2024 revenue and EPS?
Fortress Biotech reported revenue of $15.1M and diluted EPS of $-0.53 for Q4 2024.
Did Fortress Biotech beat estimates in Q4 2024?
Revenue missed the consensus estimate of $16.3M by $1.2M. EPS beat the consensus estimate of $-0.79 by $0.26.
Where can I find Fortress Biotech's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-004160) directly on SEC EDGAR. The filing index links above go to sec.gov.